96 related articles for article (PubMed ID: 9720719)
41. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.
Giannoni P; Cutrona G; Totero D
Curr Mol Med; 2017; 17(1):24-33. PubMed ID: 28231754
[TBL] [Abstract][Full Text] [Related]
42. [Assessment of selected markers of apoptosis and angiogenesis in chronic lymphocytic leukemia].
Motyčková M; Smolej L; Andrýs C; Rezáčová V; Reháček V; Simkovič M; Belada D; Zák P
Vnitr Lek; 2013 Sep; 59(9):782-93. PubMed ID: 24073950
[TBL] [Abstract][Full Text] [Related]
43. Synergistic induction of apoptosis in B-cell chronic lymphocytic leukemia cells after treatment with all-trans retinoic acid in combination with interleukin-21 and rituximab.
Abbaszadeh-Goudarzi K; Shokri F; Hosseini M; Jadidi-Niaragh F; Ghalamfarsa G; Saboor-Yaraghi AA
J Cancer Res Ther; 2016; 12(4):1278-1283. PubMed ID: 28169240
[TBL] [Abstract][Full Text] [Related]
44. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
[TBL] [Abstract][Full Text] [Related]
45. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
Yoshizawa M; Miyazaki H; Kojima S
J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
[TBL] [Abstract][Full Text] [Related]
46. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
[TBL] [Abstract][Full Text] [Related]
47. Transforming growth factor-beta 1 (TGF beta 1) enhances apoptosis in human papillomavirus type 16-immortalized human ectocervical epithelial cells.
Rorke EA; Jacobberger JW
Exp Cell Res; 1995 Jan; 216(1):65-72. PubMed ID: 7529191
[TBL] [Abstract][Full Text] [Related]
48. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
49. Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells.
Bruno S; Ledda B; Tenca C; Ravera S; Orengo AM; Mazzarello AN; Pesenti E; Casciaro S; Racchi O; Ghiotto F; Marini C; Sambuceti G; DeCensi A; Fais F
Oncotarget; 2015 Sep; 6(26):22624-40. PubMed ID: 26265439
[TBL] [Abstract][Full Text] [Related]
50. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
[TBL] [Abstract][Full Text] [Related]
51. Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells.
Farahani M; Treweeke AT; Toh CH; Till KJ; Harris RJ; Cawley JC; Zuzel M; Chen H
Leukemia; 2005 Apr; 19(4):524-30. PubMed ID: 15674425
[TBL] [Abstract][Full Text] [Related]
52. Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.
Kumar SA; Hu X; Brown M; Kuschak B; Hernandez TA; Johnston JB; Gibson SB
Leuk Lymphoma; 2009 Dec; 50(12):2038-48. PubMed ID: 19860625
[TBL] [Abstract][Full Text] [Related]
53. Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia.
Jewell AP
Leuk Lymphoma; 1996 Mar; 21(1-2):43-7. PubMed ID: 8907268
[TBL] [Abstract][Full Text] [Related]
54. Expression and regulation of COP1 in chronic lymphocytic leukemia cells for promotion of cell proliferation and tumorigenicity.
Fu C; Gong Y; Shi X; Shi H; Wan Y; Wu Q; Xu K
Oncol Rep; 2016 Mar; 35(3):1493-500. PubMed ID: 26717976
[TBL] [Abstract][Full Text] [Related]
55. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
[TBL] [Abstract][Full Text] [Related]
56. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
[TBL] [Abstract][Full Text] [Related]
57. TGF-beta and its receptor complex in leukemic B-cell precursors.
Buske C; Becker D; Feuring-Buske M; Hannig H; Griesinger F; Hiddemann W; Wörmann B
Exp Hematol; 1998 Nov; 26(12):1155-61. PubMed ID: 9808055
[TBL] [Abstract][Full Text] [Related]
58. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
[TBL] [Abstract][Full Text] [Related]
59. Aberrant glycosylation of L-selectin on the lymphocytes of chronic lymphocytic leukemia.
Prystas EM; Parker CJ; Holguin MH; Bohnsack JF
Leukemia; 1993 Sep; 7(9):1355-62. PubMed ID: 7690438
[TBL] [Abstract][Full Text] [Related]
60. Growth and survival of B-chronic lymphocytic leukaemia cells.
Söderberg O
Med Oncol; 1998 Jul; 15(2):73-8. PubMed ID: 9789213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]